VEGFA and glioblastoma: Through activation of PI3K/Akt/Nrf2 pathway in GBM cells, VEGF produced by M2 GAMs promotes GBM cell stemness, proliferation, epithelial-mesenchymal transition (EMT), and temozolomide resistance (51, 53).